Pakistan pharmaceutical market is over US $ 1.25 billion with 450 companies registered with Ministry of Health, out of that 350 having manufacturing units in the country meeting app.80% of the local market demand. Market has shown growth of 13%(IMS Qtr 3/10).Ministry of Health has registered over forty thousand brands representing over fourteen hundred molecules. Major therapeutic areas are anti-infective, GIT, anti inflammatory, analgesics, cardiovascular and CNS. National pharmaceutical industry has made tremendous progress during the last few years. Value-wise share of National pharmaceutical industry in Pakistan’s total drug market is between 55-60% whereas unit-wise its share has increased to between 70-75%. Essential drugs can be imported after Ministry of Health approval and price is regulated by Ministry of Health.


Our core strategy is to in- license and market promising new advanced molecules in our selected Therapeutic Areas and those products which improve the quality of life of patients.

We are open to develop strategic partnership with those who can support us to achieve our mission.

Featured Products